GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiang Xi Sanxin Medtec Co Ltd (SZSE:300453) » Definitions » EV-to-EBIT

Jiang Xinxin Medtec Co (SZSE:300453) EV-to-EBIT : 14.05 (As of Apr. 27, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Jiang Xinxin Medtec Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Jiang Xinxin Medtec Co's Enterprise Value is ¥3,756 Mil. Jiang Xinxin Medtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥267 Mil. Therefore, Jiang Xinxin Medtec Co's EV-to-EBIT for today is 14.05.

The historical rank and industry rank for Jiang Xinxin Medtec Co's EV-to-EBIT or its related term are showing as below:

SZSE:300453' s EV-to-EBIT Range Over the Past 10 Years
Min: -1199.54   Med: 32.78   Max: 91.37
Current: 13.83

During the past 13 years, the highest EV-to-EBIT of Jiang Xinxin Medtec Co was 91.37. The lowest was -1199.54. And the median was 32.78.

SZSE:300453's EV-to-EBIT is ranked better than
63.28% of 463 companies
in the Medical Devices & Instruments industry
Industry Median: 19.9 vs SZSE:300453: 13.83

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Jiang Xinxin Medtec Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥3,755 Mil. Jiang Xinxin Medtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥267 Mil. Jiang Xinxin Medtec Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.12%.


Jiang Xinxin Medtec Co EV-to-EBIT Historical Data

The historical data trend for Jiang Xinxin Medtec Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiang Xinxin Medtec Co EV-to-EBIT Chart

Jiang Xinxin Medtec Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.60 29.59 24.52 14.32 15.13

Jiang Xinxin Medtec Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.04 16.84 16.59 15.13 14.04

Competitive Comparison of Jiang Xinxin Medtec Co's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Jiang Xinxin Medtec Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiang Xinxin Medtec Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jiang Xinxin Medtec Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jiang Xinxin Medtec Co's EV-to-EBIT falls into.



Jiang Xinxin Medtec Co EV-to-EBIT Calculation

Jiang Xinxin Medtec Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3755.598/267.351
=14.05

Jiang Xinxin Medtec Co's current Enterprise Value is ¥3,756 Mil.
Jiang Xinxin Medtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥267 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiang Xinxin Medtec Co  (SZSE:300453) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Jiang Xinxin Medtec Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=267.351/3754.83313
=7.12 %

Jiang Xinxin Medtec Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥3,755 Mil.
Jiang Xinxin Medtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥267 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiang Xinxin Medtec Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Jiang Xinxin Medtec Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiang Xinxin Medtec Co (SZSE:300453) Business Description

Traded in Other Exchanges
N/A
Address
No. 999 Fushan Road, Xiaolan Economic and Technological Development Zone, Jiangxi, Nanchang, CHN, 330200
Jiang Xi Sanxin Medtec Co Ltd is engaged in researching and developing, manufacturing and marketing of medical devices. Its products include four series: blood purification, indwelling catheters, injections, infusion and blood transfusion. Blood purification products are used in clinical dialysis treatment for uremic patients. Indwelling catheter products represented by venous indwelling needles, positive pressure indwelling needles, central venous catheters. Injectable products mainly include self-destructing syringes, retracting self-destructing syringes, conjoined syringes.

Jiang Xinxin Medtec Co (SZSE:300453) Headlines

No Headlines